Cagrilintide Side Effects: Complete Safety Profile 2026

If you’re considering cagrilintide for weight loss, you’re probably wondering about the side effects before starting treatment.

Based on our research of the REDEFINE clinical trials and real user experiences, the most common cagrilintide side effects include nausea (47-55%), injection site reactions (43%), constipation (21%), and fatigue (20%).

I’ve spent considerable time analyzing the clinical trial data from Novo Nordisk’s phase 3 studies and gathering real patient experiences from Reddit communities to give you the complete picture.

In this comprehensive guide, you’ll learn exactly what side effects to expect, their severity ratings, when they typically occur during treatment, and practical strategies to manage them.

ContentsTable of Contents

1. 1What Is Cagrilintide?→
2. 2How Cagrilintide Works and Why Side Effects Occur?→
3. 3The Primary Mechanisms→
4. 4Common Cagrilintide Side Effects From Clinical Trials→
5. 5Understanding the Severity Classifications→
6. 6The Dose Escalation Pattern→
7. 7Anti-Cagrilintide Antibodies→
8. 8Serious Side Effects and Complications→
9. 9Acute Cholelithiasis (Gallstones)→
10. 10Pancreatitis Risk→
11. 11Bowel Obstruction→
12. 12Gastroparesis→
13. 13When to Seek Immediate Medical Attention?→
14. 14Real User Experiences: What Reddit Users Report→
15. 15Common Complaints From Users→
16. 16Valuable Tips From the Community→
17. 17Positive Experiences→
18. 18Who Should Not Take Cagrilintide?→
19. 19Absolute Contraindications→
20. 20Use With Caution→
21. 21Special Populations→
22. 22Cagrilintide vs Semaglutide vs CagriSema: Side Effect Comparison→
23. 23Key Differences→
24. 24How to Manage Cagrilintide Side Effects?→
25. 25Managing Nausea→
26. 26Managing Constipation→
27. 27Managing Injection Site Reactions→
28. 28Managing Sleep Disruption→
29. 29Frequently Asked Questions→
30. 30What are the most common side effects of cagrilintide?→
31. 31How long do cagrilintide side effects last?→
32. 32Is cagrilintide FDA approved?→
33. 33Who should not take cagrilintide?→
34. 34Does cagrilintide cause nausea?→
35. 35How does cagrilintide compare to semaglutide for side effects?→
36. 36How long does cagrilintide stay in your system?→
37. 37Can cagrilintide cause pancreatitis?→
38. 38The Bottom Line on Cagrilintide Side Effects→

What Is Cagrilintide?

Cagrilintide is a long-acting amylin analog peptide developed by Novo Nordisk for weight management and obesity treatment.

Unlike GLP-1 receptor agonists like semaglutide or tirzepatide, cagrilintide belongs to a different drug class called DACRA (Dual Amylin and Calcitonin Receptor Agonist).

The medication is administered as a once-weekly subcutaneous injection, similar to popular GLP-1 medications.

One critical factor that affects the side effect profile is cagrilintide’s extended half-life of 7.3-8 days (159-195 hours). This means the medication stays in your system much longer than daily medications, and any side effects you experience may persist for several days.

In the REDEFINE clinical trials, participants taking cagrilintide achieved 20.4-22.7% mean weight reduction over 68 weeks, compared to 2.3-3.0% with placebo. However, this impressive efficacy comes with a side effect profile that every potential user should understand.

How Cagrilintide Works and Why Side Effects Occur?

Cagrilintide works by binding to amylin and calcitonin receptors in the brain, specifically in areas that control appetite and satiety.

Understanding this mechanism helps explain why certain side effects occur.

The Primary Mechanisms

• Satiety Enhancement: Cagrilintide signals to your brain that you’re full, reducing hunger between meals
• Gastric Emptying Delay: The medication slows how quickly food leaves your stomach, which directly causes many gastrointestinal side effects
• Appetite Suppression: Signals sent to the brainstem reduce overall appetite and food-seeking behavior

The delayed gastric emptying is the primary reason users experience nausea, constipation, and bloating. When food sits in your stomach longer, these symptoms are a natural consequence.

This extended half-life is why clinical trials use a gradual dose escalation schedule over 16 weeks, allowing your body to adjust slowly to the medication’s effects.

Common Cagrilintide Side Effects From Clinical Trials

The REDEFINE clinical trials provide the most comprehensive data on cagrilintide side effects. Here’s what the research shows, with severity classifications based on reported outcomes.

Side Effect	Incidence Rate	Severity	Typical Duration	When It Occurs
Nausea	47-55%	Mild to Moderate	Transient	Peaks during dose escalation
Injection Site Reactions	43%	Mild	Temporary (24-72 hours)	After each injection
Constipation	21%	Mild to Moderate	May persist	Throughout treatment
Fatigue/Tiredness	20%	Mild	Transient	First weeks of treatment
Allergic Reactions	10%	Mild	Variable	Can occur anytime
Vomiting	8%	Mild to Moderate	During escalation	Dose escalation period
Diarrhea	7%	Mild	Transient	Early treatment
Headache	7%	Mild	Transient	First weeks
Dyspepsia (Indigestion)	4%	Mild	Transient	With meals

Understanding the Severity Classifications

Mild: Side effects that don’t significantly impact daily activities and typically resolve without intervention.

Moderate: Side effects that may require management strategies but don’t necessitate stopping treatment.

Severe: Side effects requiring medical attention or discontinuation of medication (rare with common side effects).

The Dose Escalation Pattern

Clinical trial data shows that most gastrointestinal side effects follow a predictable pattern tied to the dose escalation schedule.

1. Weeks 1-4 (0.25mg): Initial side effects begin; nausea is most common but typically mild
2. Weeks 5-8 (0.5mg): Side effects may intensify as dose increases
3. Weeks 9-12 (1.0mg): Peak side effect period for many users
4. Weeks 13-16 (1.7mg): Side effects often begin to decrease as body adjusts
5. Week 17+ (2.4mg maintenance): Most users report significant reduction in side effects

The prevalence of nausea, diarrhea, and vomiting peaked during dose escalation and decreased thereafter, according to data published in the New England Journal of Medicine.

Anti-Cagrilintide Antibodies

One notable finding from clinical trials is the development of anti-cagrilintide antibodies.

By week 26, 46-73% of participants developed these antibodies. However, researchers found no impact on medication efficacy or serious adverse reactions related to antibody formation.

This means the antibody development, while common, doesn’t appear to be a safety concern or affect how well the medication works.

Serious Side Effects and Complications

While most cagrilintide side effects are mild to moderate, certain serious complications require immediate medical attention.

Acute Cholelithiasis (Gallstones)

Rapid weight loss medications, including cagrilintide, may increase the risk of gallstone formation.

One case of acute cholelithiasis was reported in phase 2 clinical trials. Symptoms include severe upper right abdominal pain, especially after eating fatty foods, nausea, and vomiting.

Pancreatitis Risk

Based on the medication class, there is a potential risk of pancreatitis, though clinical trial data on cagrilintide-specific pancreatitis rates is limited.

Symptoms of pancreatitis include severe abdominal pain that radiates to the back, nausea, vomiting, and fever. Contact your healthcare provider immediately if you experience these symptoms.

Bowel Obstruction

Due to the medication’s effect on slowing gastric emptying, there is a rare potential risk of bowel obstruction.

This risk may be elevated in patients with pre-existing gastrointestinal conditions or a history of abdominal surgery.

Gastroparesis

Cagrilintide may exacerbate pre-existing gastroparesis (delayed stomach emptying). If you already have gastroparesis, discuss the risks carefully with your healthcare provider before starting treatment.

When to Seek Immediate Medical Attention?

Contact your healthcare provider or seek emergency care if you experience:

• Severe, persistent abdominal pain
• Persistent vomiting lasting more than 24 hours
• Signs of allergic reaction (hives, swelling, difficulty breathing)
• Symptoms of thyroid tumors (lump in neck, hoarseness, trouble swallowing)
• Severe constipation with abdominal distension
• Signs of dehydration from prolonged nausea/vomiting

Real User Experiences: What Reddit Users Report

Clinical trial data tells part of the story, but real user experiences provide insights that often don’t appear in research publications.

I analyzed discussions from r/cagrilintide, r/Mounjaro, and related communities to understand what actual users experience. This is content no competitor covers, and these insights may be particularly valuable if you’re considering cagrilintide.

Common Complaints From Users

Gastrointestinal Effects: Users report that cagrilintide has ‘slowed down movement in intestines,’ leading to gas and bloating that can be uncomfortable throughout the day.

Sleep Disruption: Multiple users describe difficulty falling asleep, restlessness, and sleeping only 2 hours at a time. One user described it as their ‘brain bouncing around’ making it impossible to relax.

Mental Restlessness: A side effect less discussed in clinical literature is the mental restlessness users experience, particularly after the first few doses. This includes feeling ‘wired’ despite being tired.

“First dose side effects: nausea and severe restlessness. Brain bouncing around feeling. Cannot fall asleep and when managing to sleep, only getting 2 hours max.”

– Reddit user, r/cagrilintide

Valuable Tips From the Community

Experienced users share several helpful insights:

• Remember the half-life: At 159-195 hours, side effects persist longer than with daily medications. Plan accordingly.
• Different from GLP-1s: Even if you tolerated Ozempic or Mounjaro well, cagrilintide may affect you differently. It works through a distinct mechanism.
• Start low and slow: Users emphasize the importance of the gradual dose escalation to minimize side effects.

Positive Experiences

Not all user experiences are negative. Some report that cagrilintide was effective when they had plateaued on other medications like Mounjaro.

The different mechanism provides an alternative pathway for weight loss when GLP-1 resistance develops.

Who Should Not Take Cagrilintide?

Certain medical conditions and situations make cagrilintide use inadvisable or require careful consideration with your healthcare provider.

Absolute Contraindications

1. Personal or Family History of Medullary Thyroid Carcinoma (MTC): Amylin analogs may increase the risk of MTC. If you or a family member has had this type of thyroid cancer, cagrilintide is contraindicated.
2. Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2): This genetic condition increases MTC risk, making cagrilintide inappropriate.
3. Pregnancy and Breastfeeding: The safety of cagrilintide during pregnancy and breastfeeding has not been established. Weight loss is not recommended during pregnancy.
4. Severe Renal Impairment: Patients with eGFR below 30 mL/min/1.73 m squared should not use cagrilintide due to limited safety data in this population.

Use With Caution

Severe Gastrointestinal Conditions: Patients with gastroparesis, chronic gastrointestinal dysmotility, or history of bowel obstruction should discuss risks carefully with their healthcare provider.

History of Pancreatitis: While not an absolute contraindication, patients with a history of pancreatitis should be monitored closely.

Patients Taking Other Weight Loss Medications: The safety of combining cagrilintide with other appetite suppressants or weight loss medications has not been established.

Special Populations

Elderly Patients: Limited data exists for patients over 75. Use with caution and careful monitoring.

Patients with Diabetes: Cagrilintide affects blood sugar levels. Close monitoring and potential adjustment of diabetes medications may be necessary.

Cagrilintide vs Semaglutide vs CagriSema: Side Effect Comparison

Understanding how cagrilintide’s side effect profile compares to other weight loss medications helps inform treatment decisions.

Comparison	Cagrilintide (Monotherapy)	Semaglutide (Wegovy)	CagriSema (Combination)
Nausea	47-55%	44%	Similar to components
Injection Site Reactions	43%	6%	Higher than semaglutide alone
Constipation	21%	24%	Similar
Discontinuation Rate	~10%	~7%	5.9-8.4%
Weight Loss	20.4-22.7%	15-17%	22.7% (REDEFINE 1)
Primary Mechanism	Amylin receptor	GLP-1 receptor	Dual mechanism

Key Differences

Injection Site Reactions: Cagrilintide shows significantly higher injection site reaction rates (43%) compared to semaglutide (6%). This is an important consideration for patients concerned about injection tolerance.

Discontinuation Rates: Interestingly, CagriSema (the combination) has lower discontinuation rates (5.9-8.4%) than cagrilintide monotherapy (~10%), suggesting the combination may be better tolerated for some patients.

Different Mechanism: Because cagrilintide works through amylin receptors rather than GLP-1 receptors, patients who experience intolerable side effects from semaglutide might tolerate cagrilintide differently, and vice versa.

How to Manage Cagrilintide Side Effects?

Most cagrilintide side effects can be managed without discontinuing treatment. Here are evidence-based strategies from clinical recommendations and real user experiences.

Managing Nausea

• Eat smaller, more frequent meals throughout the day
• Avoid fatty, greasy, or spicy foods
• Stay well-hydrated, but avoid drinking large amounts with meals
• Eat slowly and stop eating when you feel full
• Consider anti-nausea medications (consult your healthcare provider)

Managing Constipation

• Increase fiber intake gradually
• Drink plenty of water (aim for 8+ glasses daily)
• Stay physically active
• Consider over-the-counter stool softeners if needed (consult provider first)

Managing Injection Site Reactions

• Rotate injection sites with each dose
• Allow the medication to reach room temperature before injection
• Apply a cold compress after injection if needed
• Ensure proper injection technique (subcutaneous, not intramuscular)

Managing Sleep Disruption

Based on Reddit user experiences, sleep disruption can be challenging:

• Maintain consistent sleep and wake times
• Avoid caffeine after noon
• Consider timing your injection earlier in the week if symptoms peak on certain days
• Discuss with your healthcare provider if sleep issues persist

Frequently Asked Questions

The Bottom Line on Cagrilintide Side Effects

Based on our research of the REDEFINE clinical trials and real user experiences, cagrilintide’s side effect profile is generally manageable for most patients.

The most common side effects are gastrointestinal (nausea, constipation) and injection site reactions. These typically peak during dose escalation and improve once reaching maintenance dosing.

What sets cagrilintide apart is its extended half-life of 7-8 days, which means both benefits and side effects persist longer than daily medications. This is an important consideration when deciding whether cagrilintide is right for you.

The real user experiences from Reddit reveal side effects not always prominent in clinical literature, particularly sleep disruption and mental restlessness. These are worth discussing with your healthcare provider.

If you’re considering cagrilintide for weight management, work closely with a licensed healthcare provider who can assess your individual risk factors, monitor for serious complications, and help you manage any side effects that arise.